NCT00787293 - Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2015

Conditions

Heart FailureMitral Regurgitation

Interventions

DEVICE

PTMA (Percutaneous Transvenous Mitral Annuloplasty) Implant

Percutaneous assessment from right or left subclavian vein, with PTMA implant in the coronary sinus, great cardiac vein, anterior interventricular vein.

Trial Locations (13)

1211

Hôpital Universitaire de Genève, Geneva

B-9300

Onze Lieve Vrouw Ziekenhuis Cardiovasculair Ondrezoek Aalst, Aalst

B-4000

Centre Hospitalier Universitaire de Liège, Liège

1958/9

Institut Klinicke a Experimentalni Mediciny, Prague

D-52074

Rheinisch-Westfalische Technische Hochschule Universitaetsklinikum Aachen, Aachen

D-32545

Herz-und Diabeteszentrum Nordrhein-Westfalen / Ruhr University of Bochum, Bad Oeynhausen

D-45122

Universitaet Duisburg-Essen Westdeutsches Herzzentrum Universitaetsklinikum Essen, Essen

D-60389

CardioVascular Center Frankfurt Sankt Katharinen, Frankfurt

D-79095

Albert-Ludwigs-Universitat Freiburg Mediziniche Universitätsklinikum Freiburg, Freiburg im Breisgau

D-76133

Städtische Klinikum Karlsruhe GmbH, Karlsruhe

D-80804

Klinikum Schwabing Städtisches Klinikum München GmbH, München

N-3015

Thoraxcentrum Erasmus Medisch Centrum, Rotterdam

N-3584

Universitair Medisch Centrum Utrecht, Utrecht